ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Alhemo®, Injektionslösung im Fertigpen:Novo Nordisk Pharma AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 
B02BX10 - ConcizumabATC-DDD Version 2016. Source: WHO
B - Blood and Blood Forming Organs
 
B02 - Antihemorrhagics
 
B02B - Vitamin K and Other Hemostatics
 

The DDDs are based on treatment of hemorrhage associated with different deficiency states (e.g. vitamin K deficiency, deficiency of different blood coagulation factors etc.).

B02BX - Other Systemic Hemostatics

This group comprises systemic hemostatics, which cannot be classified elsewhere.

The DDD for avatrombopag is based on the starting dose in the treatment of chronic immune thrombocytopenia.

B02BX10 - Concizumab
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home